Development of a gLCR-based KRAS mutation detection approach and its comparison with other screening methods

Stefan Jenner1, Dieter Techel

  • 1Division of Molecular Pathology, Department of Pathology, Katharinen Hospital Stuttgart, Kriegsbergstr. 60, 70374, Stuttgart, Germany, s.jenner@klinikum-stuttgart.de.

Summary

A novel gapped ligase chain reaction (gLCR) technique accurately detects low-level KRAS mutations in colorectal cancer tissues. This highly sensitive method confirms doubtful results from other screening techniques with high reproducibility.